{"id":430014,"date":"2019-09-19T17:10:01","date_gmt":"2019-09-19T17:10:01","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=430014"},"modified":"2019-09-19T17:10:01","modified_gmt":"2019-09-19T17:10:01","slug":"car-t-cell-therapy-market-top-companies-analysis-size-drugs-growth-by-upcoming-treatments-recent-trends-and-top-regions-forecast-to-2025","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/car-t-cell-therapy-market-top-companies-analysis-size-drugs-growth-by-upcoming-treatments-recent-trends-and-top-regions-forecast-to-2025_430014.html","title":{"rendered":"CAR T Cell Therapy Market Top Companies Analysis, Size, Drugs, Growth by Upcoming Treatments, Recent Trends, and Top Regions Forecast to 2025"},"content":{"rendered":"
The Global CAR T Cell Therapy Market is expected to register a CAGR of 58.52% to reach USD 8716.06 Million by 2025. Global CAR T Cell Therapy Market: Information by Target Antigen (CD19, CD22 and others), Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma and others) and Region – Forecast till 2025\n<\/div>\n

The Global CAR T Cell Therapy Market is expected to register a CAGR of 58.52% during the forecast period, with a market value of USD 346.75 Million in 2018. <\/strong><\/p>\n

Regional Analysis – CAR T Cell Therapy Market<\/strong><\/p>\n

The global CAR T cell therapy market, based on region, is divided into the US, Europe, China, and the rest of the world.<\/p>\n

The US is expected to hold the largest share of the global CAR T cell therapy market. This is owing to the increasing cases of cancer in the country. Europe showed a considerable amount of growth in the market due to an increase in the occurrences of hematologic cancer such as leukemia, lymphoma, and multiple myeloma. Europe held a market share of 9.15%<\/strong> in the global CAR T cell therapy market. China is estimated to significantly grow in the global market due to the developing healthcare infrastructure and increasing disposable income. Also, the market in the Middle East & Africa is expected to show the least growth owing to limited healthcare access and affordability among the population.<\/p>\n

Get Exclusive Sample Copy of “CAR T Cell Therapy Market” Report @ <\/em><\/strong>https:\/\/www.marketresearchfuture.com\/sample_request\/8102<\/a><\/p>\n

CAR T Cell Therapy Market – Sketch<\/strong><\/p>\n

Chimeric Antigen Receptor (CAR) T Cell Therapy is an immunotherapy used for cancer treatment. In this therapy, T cells from patient body are isolated and inserted in the CAR gene so that the gene for the specific receptor binds to a certain protein on the patient’s cancer cells.<\/p>\n

Growing prevalence of cancer across the world, technological advancement for advanced & reliable treatment for cancer, and rise in the number of cell therapy clinical studies are driving the growth of the global CAR T Cell Therapy market. According to the National Cancer Institute, it is estimated that 1,735,350 new cases of cancer were diagnosed, and 609,640 deaths were reported in the US in 2018. Moreover, the growing pharmaceutical industry is also expected to boost market growth.<\/p>\n

Key Players – CAR T Cell Therapy Market<\/strong><\/p>\n

Market Research Future (MRFR) recognizes the following companies as the key players in CAR T Cell Therapy Market: There are plenty of large and small market players which operate in this market all over the globe.<\/p>\n

Market Research Future (MRFR) recognizes the following companies as key players in the global CAR T Cell therapy market that include Novartis AG (Switzerland), Pfizer, Inc. (US), Kite Pharma (US), Cellectis (France), Autolus Therapeutics PLC (UK), CARsgen Therapeutics (China), Juno Therapeutics (US), Sorrento Therapeutics (US), Legend Biotech (US), Mustang Bio (US), and others.<\/strong><\/p>\n

Segments – CAR T Cell Therapy Market<\/strong><\/p>\n

The global CAR T cell therapy market, by target antigen, has been segmented into CD19, CD22, and others. The CD19 target antigen segment accounted for a value of USD 342.56 million in 2018<\/strong>. On the basis of application, the global CAR T cell therapy market is segmented into acute lymphoblastic leukemia, diffuse large B-cell lymphoma, and others.<\/p>\n

Key Questions Answered In This Report:<\/strong><\/p>\n

What will the market size and what will the growth rate be?<\/p>\n

What are the key market trends?<\/p>\n

What is driving this market?<\/p>\n

What are the challenges to market growth?<\/p>\n

Who are the key vendors in this market space?<\/p>\n

What are the market opportunities and threats faced by the key vendors?<\/p>\n

What are the strengths and weaknesses of the key vendors?<\/p>\n

Some Brief Table of Contents of Report<\/strong><\/p>\n

Chapter 1. Report Prologue<\/strong><\/p>\n

Chapter 2. Market Introduction<\/strong><\/p>\n

2.1 Definition<\/p>\n

2.2 Scope Of The Study<\/p>\n

2.2.1 Research Objective<\/p>\n

2.2.2 Assumptions<\/p>\n

2.2.3 Limitations<\/p>\n

Chapter 3. Research Methodology<\/strong><\/p>\n

3.1 Introduction<\/p>\n

3.2 Primary Research<\/p>\n

3.3 Secondary Research<\/p>\n

3.4 Market Size Estimation<\/p>\n

Chapter 4. Market Dynamics<\/strong><\/p>\n

4.1 Drivers<\/p>\n

4.2 Restrains<\/p>\n

4.3 Opportunities<\/p>\n

4.4 Challenges<\/p>\n

4.5 Macroeconomic Indicators<\/p>\n

4.6 Technology Trends & Assessment<\/p>\n

Chapter 5. Market Factor Analysis<\/strong><\/p>\n

5.1 Porters Five Forces Analysis<\/p>\n

5.1.1 Bargaining Power Of Suppliers<\/p>\n

TOC Continued…<\/strong><\/p>\n

Browse Complete “CAR T Cell Therapy Market” Report @<\/strong><\/em> https:\/\/www.marketresearchfuture.com\/reports\/car-t-cell-therapy-market-8102<\/a><\/p>\n

LIST OF TABLES<\/strong><\/p>\n

TABLE 1 PRIMARY INTERVIEWS 16<\/p>\n

TABLE 2 CLINICAL TRIALS OVERVIEW 28<\/p>\n

TABLE 3 GLOBAL CAR T CELL THERAPY MARKET BY TARGET ANTIGEN, 2017-2025 (USD MILLION) 37<\/p>\n

TABLE 4 GLOBAL CAR T CELL THERAPY MARKET FOR CD19, BY REGION, 2017-2025 (USD MILLION) 37<\/p>\n

TABLE 5 GLOBAL CAR T CELL THERAPY MARKET FOR CD22, BY REGION, 2017-2025 (USD MILLION) 38<\/p>\n

TABLE 6 GLOBAL CAR T CELL THERAPY MARKET BY APPLICATION, 2017-2025 (USD MILLION) 40<\/p>\n

Continued…<\/strong><\/p>\n

LIST OF FIGURES<\/strong><\/p>\n

FIGURE 1 MARKET SYNOPSIS 11<\/p>\n

FIGURE 2 MARKET ATTRACTIVENESS ANALYSIS: GLOBAL CAR T CELL THERAPY MARKET 12<\/p>\n

FIGURE 3 GLOBAL CAR T CELL THERAPY MARKET SHARE, BY TARGET ANTIGEN, 2018 (%) 12<\/p>\n

FIGURE 4 GLOBAL CAR T CELL THERAPY MARKET BY TARGET ANTIGEN, 2017–2025 (USD MILLION) 13<\/p>\n

FIGURE 5 GLOBAL CAR T CELL THERAPY MARKET SHARE, BY APPLICATION, 2018 (%) 13<\/p>\n

FIGURE 6 GLOBAL CAR T CELL THERAPY MARKET BY APPLICATION, 2017–2025 (USD MILLION) 14<\/p>\n

FIGURE 7 GLOBAL CAR T CELL THERAPY MARKET: MARKET STRUCTURE 15<\/p>\n

Continued…<\/strong><\/p>\n

About Market Research Future:<\/strong><\/p>\n

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Market Research Future<\/a>
Contact Person:<\/strong> Abhishek Sawant
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +1 646 845 9312
Address:<\/strong>Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City:<\/strong> Pune
State:<\/strong> Maharashtra
Country:<\/strong> India
Website:<\/strong> https:\/\/www.marketresearchfuture.com\/reports\/car-t-cell-therapy-market-8102<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

The Global CAR T Cell Therapy Market is expected to register a CAGR of 58.52% to reach USD 8716.06 Million by 2025. Global CAR T Cell Therapy Market: Information by Target Antigen (CD19, CD22 and others), Application (Acute Lymphoblastic Leukemia, … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,412],"tags":[],"class_list":["post-430014","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-News-Current-Affairs"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/430014","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=430014"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/430014\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=430014"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=430014"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=430014"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}